UCSF

ZINC00020220

Substance Information

In ZINC since Heavy atoms Benign functionality
September 26th, 2005 24 Yes

Other Names:

oxacin

1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7(1-piperazinyl)-3-quinolinecarboxylic acid

1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid hydrochloride hydrate; 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid hydrochloride monohydrate; ciprofloxacin hydrochloride; cipr

1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid; 3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperaz

1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; CPD-12

1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4 -dihydro-3-quinolinecarboxylic acid hydrochloride

1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid

1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid hydrochloride

1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 2-hydroxypropanoic acid

1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride

1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride hydrate

1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid

1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid; 1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline

1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid

1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid hydrochloride

1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid; 2-hydroxypropanoic acid

1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid

3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-

3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride

3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, monohydrochloride

677

85721-33-1; C05349; Ciprofloxacin

86393-32-0; CPFX; Ciloxan (TN); Cipro (TN); Ciprofloxacin hydrochloride (JAN/USP); D02216; Proquin XR (TN)

93107-08-5; Ciprofloxacin hydrochloride; Prestwick_67

97867-33-9; Ciprofloxacin lactate; Ciproxin (TN); D07702

Bacquinor

BAN

BAY-O-9867

Bay-o-9867 monohydrate

BAY-Q-3939

BAY-Q-3939; BAY-O-9867 Monohydrate; BAY-O-9867

BAY-Q-3939; BAY-O-9867; BAY-O-9867 Monohydrate

Baycip

Belmacina

Bernoflox

BRD-K04804440-311-02-3

Catex

Ceprimax

Cetraxal

CHEBI:41638; CHEBI:3717; CHEBI:102718

Ciflox

Cifloxin

Cilox

Ciloxan

Ciprenit

Ciprinol

Cipro

Cipro I.V.

Cipro Inhale

Cipro XL

Cipro XR

Ciprobay

Ciprocinol

Ciprodar

Ciprofloxacin (BAN

Ciprofloxacin (Cipro)

Ciprofloxacin (FDA

Ciprofloxacin dihydrochloride

Ciprofloxacin GR

Ciprofloxacin HCl

Ciprofloxacin HCl monohydrate

Ciprofloxacin hydrochloride

ciprofloxacin hydrochloride hydrate

Ciprofloxacin hydrochloride monohydrate

Ciprofloxacin Lactate

Ciprofloxacin monohydrochloride

Ciprofloxacin monohydrochloride;Ciprofloxacina

Ciprofloxacin XR

Ciprofloxacin, 98%

Ciprofloxacin, Ciprofloxacin Hydrochloride

CIPROFLOXACIN; CIPROFLOXACIN EXTENDED RELEASE; CIPROFLOXACIN HYDROCHLORIDE; LS-187906

ciprofloxacin; ciprofloxacine; ciprofloxacino; ciprofloxacinum

Ciprofloxacina

ciprofloxacinlactate

Ciprok

Cipromycin

Ciproquinol

Ciproxan

Ciproxin

Ciproxine

Cunesin

CYCLOPROPYLFLUOROOXOPIPERAZINYLDIHYDROQUINOLINECARBOXYLICACIDHYDROCHLORID

Cyproxan

DAP001465

DF-289

Eni

Estecina

FDA

FDA)

Flociprin

Floxin

INN

JAN

LS-141566

LS-186638

MFCD00079044

MFCD00185755

MFCD00242856

MFCD01759747

N/A

Ocuflox

Oftacilox

Proquin XR

QA-6321

Rigoran

Sarf

Septicide

Septocipro

Uniflox

Uritent

USAN

USP

USP)

USP); Ciprofloxacin HCl (FDA

USP); Ciprofloxacin HCl (JAN

USP); Ciprofloxacin Hydrochloride (FDA

Utiminx

Velmonit

Velomonit

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -0.70 9.07 -109.14 2 6 0 82 331.347 3
Hi High (pH 8-9.5) -0.70 7.77 -65.4 1 6 -1 77 330.339 3
Mid Mid (pH 6-8) -3.45 7.06 -88.49 3 6 1 85 332.355 2

Vendor Notes

Note Type Comments Provided By
Molecular_Solubility 2.401 Bitter DB
biological_use . ZereneX Building Blocks
ALOGPS_SOLUBILITY 1.35e+00 g/l DrugBank-approved
MP 271 - 273 Enamine Building Blocks
MP 271...273 Enamine Building Blocks
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 95% Fluorochem
Purity 96% Fluorochem
Therapy antibacterial, fungicide SMDC Pharmakon
Indications antibiotic KeyOrganics Bioactives
biological_use Broad spectrum antibacterial agent (used in treatment of Legionnaire's disease) IBScreen Bioactives IBScreen Bioactives
Indications broad-spectrum antibiotic KeyOrganics Bioactives
mechanism DNA gyrase (type II topoisomerase) and topoisomerase IV inhibitor IBScreen Bioactives
UniProt Database Links FLQE1_MYCTU; FLQE2_MYCTU; FLQE3_MYCTU; GYRA_STAA3; MDTK_ECOLI; MEPA_STAA8; NORB_STAA8; NORM_VIBCH; NORM_VIBPA; SBCC_STAA8; SBCC_STAAE; SBCD_STAA8; SBCD_STAAE ChEBI
Warnings IRRITANT Matrix Scientific
Target Others Selleck Chemicals
biological_use Provides postexposure protection against exp. inhalation anthrax ( Bacillus anthracis ) IBScreen Bioactives

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
GYRA-1-B DNA Gyrase Subunit A (cluster #1 Of 1), Bacterial Bacteria 500 0.37 Binding ≤ 10μM
GYRB-1-B DNA Gyrase Subunit B (cluster #1 Of 1), Bacterial Bacteria 500 0.37 Binding ≤ 10μM
PARC-1-B Topoisomerase IV Subunit A (cluster #1 Of 1), Bacterial Bacteria 2300 0.33 Binding ≤ 10μM
GYRA-1-B DNA Gyrase Subunit A (cluster #1 Of 1), Bacterial Bacteria 200 0.39 Functional ≤ 10μM
GYRB-1-B DNA Gyrase Subunit B (cluster #1 Of 1), Bacterial Bacteria 200 0.39 Functional ≤ 10μM
PARC-1-B Topoisomerase IV Subunit A (cluster #1 Of 1), Bacterial Bacteria 2500 0.33 Functional ≤ 10μM
KCNH2-1-E HERG (cluster #1 Of 5), Eukaryotic Eukaryotes 3020 0.32 Binding ≤ 10μM
TOP2A-1-E DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic Eukaryotes 30 0.44 Binding ≤ 10μM
TOP2B-1-E DNA Topoisomerase II Beta (cluster #1 Of 2), Eukaryotic Eukaryotes 30 0.44 Binding ≤ 10μM
Z104301-1-O GABA-A Receptor; Anion Channel (cluster #1 Of 8), Other Other 410 0.37 Binding ≤ 10μM
Z50117-1-O Pseudomonas Aeruginosa (cluster #1 Of 2), Other Other 220 0.39 Functional ≤ 10μM
Z50185-3-O Staphylococcus Aureus (cluster #3 Of 4), Other Other 400 0.37 Functional ≤ 10μM
Z50212-1-O Escherichia Coli (cluster #1 Of 7), Other Other 10 0.47 Functional ≤ 10μM
Z50378-1-O Mycobacterium Intracellulare (cluster #1 Of 1), Other Other 910 0.35 Functional ≤ 10μM
Z50380-1-O Mycobacterium Smegmatis (cluster #1 Of 4), Other Other 1980 0.33 Functional ≤ 10μM
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 9440 0.29 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
GYRA_ECOLI P0AES4 DNA Gyrase Subunit A, Ecoli 300 0.38 Binding ≤ 1μM
GYRB_ECOLI P0AES6 DNA Gyrase Subunit B, Ecoli 300 0.38 Binding ≤ 1μM
TOP2A_HUMAN P11388 DNA Topoisomerase II Alpha, Human 30 0.44 Binding ≤ 1μM
TOP2B_HUMAN Q02880 DNA Topoisomerase II Beta, Human 30 0.44 Binding ≤ 1μM
Z104301 Z104301 GABA-A Receptor; Anion Channel 410 0.37 Binding ≤ 1μM
PARC_STAAU P0C1U9 Topoisomerase IV Subunit A, Staau 1000 0.35 Binding ≤ 1μM
GYRA_ECOLI P0AES4 DNA Gyrase Subunit A, Ecoli 300 0.38 Binding ≤ 10μM
GYRB_ECOLI P0AES6 DNA Gyrase Subunit B, Ecoli 300 0.38 Binding ≤ 10μM
TOP2A_HUMAN P11388 DNA Topoisomerase II Alpha, Human 30 0.44 Binding ≤ 10μM
TOP2B_HUMAN Q02880 DNA Topoisomerase II Beta, Human 30 0.44 Binding ≤ 10μM
Z104301 Z104301 GABA-A Receptor; Anion Channel 410 0.37 Binding ≤ 10μM
KCNH2_HUMAN Q12809 HERG, Human 3020 0.32 Binding ≤ 10μM
PARC_STAAU P0C1U9 Topoisomerase IV Subunit A, Staau 1000 0.35 Binding ≤ 10μM
GYRA_ECOLI P0AES4 DNA Gyrase Subunit A, Ecoli 200 0.39 Functional ≤ 10μM
GYRB_ECOLI P0AES6 DNA Gyrase Subunit B, Ecoli 200 0.39 Functional ≤ 10μM
Z50212 Z50212 Escherichia Coli 0.1 0.58 Functional ≤ 10μM
Z50378 Z50378 Mycobacterium Intracellulare 1056 0.35 Functional ≤ 10μM
Z50380 Z50380 Mycobacterium Smegmatis 1070 0.35 Functional ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 1750 0.34 Functional ≤ 10μM
Z50117 Z50117 Pseudomonas Aeruginosa 220 0.39 Functional ≤ 10μM
Z50185 Z50185 Staphylococcus Aureus 1100 0.35 Functional ≤ 10μM
PARC_STAAU P0C1U9 Topoisomerase IV Subunit A, Staau 2500 0.33 Functional ≤ 10μM
PARC_ECOLI P0AFI2 Topoisomerase IV Subunit A, Ecoli 2500 0.33 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
G0 and Early G1
Voltage gated Potassium channels

Analogs ( Draw Identity 99% 90% 80% 70% )